Louis Gleckel
Fortuna: 1 038 $ al 31/05/2026
Fortuna: 1 038 $ al 31/05/2026
Dr. Louis Gleckel, MD, is an Independent Director at ProPhase Labs, Inc. He is on the Board of Directors at ProPhase Labs, Inc. Dr. Gleckel was previously employed as a Co-Founder by ProHEALTH Care Associates LLP and a Chairman by Invicta Corp.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PROPHASE LABS, INC. 0,11 % | 29/04/2025 | 10.384 ( 0,11 % ) | 1 038 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROPHASE LABS, INC. | Director/Miembro de la Junta | 01/06/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
Invicta Corp.
Invicta Corp. Medical SpecialtiesHealth Technology Manufactures and distributes optical equipment, chemicals, services, and products | Presidente | - |
Prohealth Care Associates LLP | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
ProPhase Labs, Inc.
ProPhase Labs, Inc. Pharmaceuticals: OtherHealth Technology Manufactures cold remedy products and other supplements | Health Technology |
Invicta Corp.
Invicta Corp. Medical SpecialtiesHealth Technology Manufactures and distributes optical equipment, chemicals, services, and products | Health Technology |
Prohealth Care Associates LLP |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.